000999 华润三九
交易中 07-14 13:23:30
资讯
新帖
简况
华润三九：未来会继续鼓励天士力以创新驱动业务发展
证券之星 · 07-07
华润三九：未来会继续鼓励天士力以创新驱动业务发展
华润三九：2024年研发投入9.53亿元 在研项目131项
证券之星 · 07-07
华润三九：2024年研发投入9.53亿元 在研项目131项
华润三九：感冒灵颗粒是国家批准的OTC药品
证券之星 · 07-07
华润三九：感冒灵颗粒是国家批准的OTC药品
老百姓大药房与华润三九2025年战略洽谈会圆满召开
老百姓大药房集团 · 07-04
老百姓大药房与华润三九2025年战略洽谈会圆满召开
研报掘金丨中邮证券：首予华润三九“买入”评级，与天士力发挥产业链协同效应
格隆汇 · 07-03
研报掘金丨中邮证券：首予华润三九“买入”评级，与天士力发挥产业链协同效应
研报掘金丨中邮证券：首予华润三九“买入”评级，与天士力发挥产业链协同效应
格隆汇资讯 · 07-03
研报掘金丨中邮证券：首予华润三九“买入”评级，与天士力发挥产业链协同效应
华润三九：截至6月30日公司股东共65,625户
证券之星 · 07-01
华润三九：截至6月30日公司股东共65,625户
华润三九现代中药制药等企业入围郴州市中医医院中药配方颗粒配送项目
DoNews · 06-27
华润三九现代中药制药等企业入围郴州市中医医院中药配方颗粒配送项目
华润三九内生强基固本，外延拓展边界
华泰证券 · 06-26
华润三九内生强基固本，外延拓展边界
华润三九控股子公司昆药集团为两孙公司提供1250万元担保
中访网数据 · 06-25
华润三九控股子公司昆药集团为两孙公司提供1250万元担保
研报掘金丨东吴证券：首予天士力“买入”评级，华润入主强强联合
格隆汇 · 06-23
研报掘金丨东吴证券：首予天士力“买入”评级，华润入主强强联合
华润三九：6月11日投资者关系活动记录，国联民生、中信建投等多家机构参与
证券之星 · 06-23
华润三九：6月11日投资者关系活动记录，国联民生、中信建投等多家机构参与
华润三九：公司高度重视市值管理工作
证券之星 · 06-19
华润三九：公司高度重视市值管理工作
东方妍美赴港上市 押注童颜针四年估值涨近七倍【IPO观察】
投资者网 · 06-15
东方妍美赴港上市 押注童颜针四年估值涨近七倍【IPO观察】
华润三九：截至6月10日公司股东共60483户
证券之星 · 06-13
华润三九：截至6月10日公司股东共60483户
每周股票复盘：华润三九（000999）股东户数减少，预计2025年营收双位数增长
证券之星 · 06-06
每周股票复盘：华润三九（000999）股东户数减少，预计2025年营收双位数增长
华润三九Q1营利双降，甩卖亏损资产难掩并购扩张隐忧
证券之星 · 06-06
华润三九Q1营利双降，甩卖亏损资产难掩并购扩张隐忧
华润三九：截至5月31日公司股东共58187户
证券之星 · 06-05
华润三九：截至5月31日公司股东共58187户
华润三九：5月27日投资者关系活动记录，中信证券、太平资产等多家机构参与
证券之星 · 06-04
华润三九：5月27日投资者关系活动记录，中信证券、太平资产等多家机构参与
华润三九：会加快与天士力在产品、渠道、终端等方面的协同
人民财讯 · 06-03
华润三九：会加快与天士力在产品、渠道、终端等方面的协同
加载更多
公司概况
公司名称：
华润三九医药股份有限公司
所属行业：
医药制造业
上市日期：
2000-03-09
主营业务：
华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是CHC健康消费品、处方药。报告期内，公司获得中国质量协会QC成果发表赛一等奖。
发行价格：
8.45
{"stockData":{"symbol":"000999","market":"SZ","secType":"STK","nameCN":"华润三九","latestPrice":31.28,"timestamp":1752470610000,"preClose":31.22,"halted":0,"volume":4467212,"delay":0,"changeRate":0.0019,"floatShares":1662000000,"shares":1670000000,"eps":1.9611,"marketStatus":"交易中","change":0.06,"latestTime":"07-14 13:23:30","open":31.3,"high":31.45,"low":31.2,"amount":140000000,"amplitude":0.008,"askPrice":31.28,"askSize":3,"bidPrice":31.27,"bidSize":511,"shortable":0,"etf":0,"ttmEps":1.9611,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752476400000},"marketStatusCode":2,"adr":0,"adjPreClose":31.22,"symbolType":"stock","openAndCloseTimeList":[[1752456600000,1752463800000],[1752469200000,1752476400000]],"highLimit":34.34,"lowLimit":28.1,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1669588290,"isCdr":false,"pbRate":2.46,"roa":"--","peRate":15.950232,"roe":"6.18%","epsLYR":2.63,"committee":0.483672,"marketValue":52225000000,"turnoverRate":0.0027,"status":0,"floatMarketCap":51989000000},"requestUrl":"/m/hq/s/000999","defaultTab":"news","newsList":[{"id":"2549589802","title":"华润三九：未来会继续鼓励天士力以创新驱动业务发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2549589802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549589802?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:21","pubTimestamp":1751876495,"startTime":"0","endTime":"0","summary":"同时我们会注重天士力和华润三九业务上的协同赋能，后续会加快双方在产品、渠道、终端等方面的协同，感谢您的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700020746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000999","BK0196","BK0060","BK0028","BK0188","BK0175","BK0185","BK0010","BK0183","600535","BK0239","BK0012"],"gpt_icon":0},{"id":"2549589387","title":"华润三九：2024年研发投入9.53亿元 在研项目131项","url":"https://stock-news.laohu8.com/highlight/detail?id=2549589387","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549589387?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:21","pubTimestamp":1751876490,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九07月07日在投资者关系平台上答复投资者关心的问题。身为国资委企下华润这么有实力的企业，在创新药方面的研发应该跑在全国最前面才对啊！2024年，公司研发投入9.53亿元，在研项目共计131项，主要围绕抗肿瘤、骨科、皮肤、呼吸、抗感染等治疗领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700020734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0028","BK0188","BK0060","BK0239","BK0185","000999","BK0012","BK0196","BK0010","BK0183"],"gpt_icon":0},{"id":"2549158603","title":"华润三九：感冒灵颗粒是国家批准的OTC药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2549158603","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549158603?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:18","pubTimestamp":1751876311,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九07月07日在投资者关系平台上答复投资者关心的问题。感冒灵颗粒在改善感冒症状方面效果和安全性良好。产品说明书中包含成分、功能主治、用法用量、注意事项等内容，并遵循国家规范严格编制。我司始终高度重视产品质量与用药安全，致力于为消费者提供安全、有效的药品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700020430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0196","BK0239","BK0060","BK0185","BK0010","BK0175","BK0028","000999","BK0183","BK0188"],"gpt_icon":0},{"id":"2548945360","title":"老百姓大药房与华润三九2025年战略洽谈会圆满召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2548945360","media":"老百姓大药房集团","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548945360?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:36","pubTimestamp":1751621767,"startTime":"0","endTime":"0","summary":"7月3日，老百姓大药房连锁股份有限公司与华润三九医药股份有限公司在老百姓大药房总部召开2025年战略对接会，此次会议不仅是双方高层领导的深度交流，更是医药零售与医药工业领域强强联合、共谋发展的关键契机。他表示华润三九一直是老百姓大药房的战略合作伙伴，倡导双方在多品类多渠道深化合作，实现服务健康的核心目标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704181552a72ea510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704181552a72ea510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","BK0239","BK0209","BK0060","BK0183","BK0185","603883","BK0196","BK0010","BK0012","000999","BK0028","BK0188"],"gpt_icon":0},{"id":"2548987531","title":"研报掘金丨中邮证券：首予华润三九“买入”评级，与天士力发挥产业链协同效应","url":"https://stock-news.laohu8.com/highlight/detail?id=2548987531","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548987531?lang=zh_cn&edition=full","pubTime":"2025-07-03 15:45","pubTimestamp":1751528722,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","BK0060","BK0196","BK0185","000999","BK0239","600535","BK0175","BK0010","161027","BK0183","BK0012","BK0188"],"gpt_icon":0},{"id":"2548400871","title":"研报掘金丨中邮证券：首予华润三九“买入”评级，与天士力发挥产业链协同效应","url":"https://stock-news.laohu8.com/highlight/detail?id=2548400871","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548400871?lang=zh_cn&edition=full","pubTime":"2025-07-03 15:45","pubTimestamp":1751528722,"startTime":"0","endTime":"0","summary":"2025Q1公司完成天士力28%股权的收购事项，天士力成为华润三九的控股子公司。公司将与天士力发挥产业链协同效应，在创新研发、智能制造、渠道营销等领域相互赋能，增强全产业链核心竞争力，助力公司加快补充创新中药管线，建立在中药领域的引领优势。首次覆盖，给予“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031545559798513b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031545559798513b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600535","000999","161027"],"gpt_icon":0},{"id":"2548071329","title":"华润三九：截至6月30日公司股东共65,625户","url":"https://stock-news.laohu8.com/highlight/detail?id=2548071329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548071329?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:42","pubTimestamp":1751359357,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九(000999)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新一期公司的股东人数是多少？华润三九回复：您好，截至6月30日，公司股东共65,625户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100027483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","BK0012","BK0185","BK0239","BK0188","000999","BK0196","BK0010","BK0060","BK0183"],"gpt_icon":0},{"id":"2546467947","title":"华润三九现代中药制药等企业入围郴州市中医医院中药配方颗粒配送项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2546467947","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546467947?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:05","pubTimestamp":1751029503,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年6月26日，郴州市中医医院发布中药配方颗粒配送企业公开遴选中标结果公告。本次采购项目分为两个包，分别为健康药房临方配制膏方配方颗粒和中药房配方颗粒。其中，华润三九现代中药制药有限公司成为包一的第一入围候选人，长沙新林制药有限公司和北京康仁堂药业有限公司分别为包二的第一和第二入围候选人。项目采购预算分别为20000000.00元（包一）和18000000.00元（包二），合同履行期限为3年。采购人为郴州市中医医院，代理机构为湖南新星项目管理有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062721063697916bbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062721063697916bbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0175","561510","BK0196","BK0183","BK0188","000999","BK0239","BK0010","BK0185","BK0060","562390","BK0012"],"gpt_icon":0},{"id":"2546799842","title":"华润三九内生强基固本，外延拓展边界","url":"https://stock-news.laohu8.com/highlight/detail?id=2546799842","media":"华泰证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546799842?lang=zh_cn&edition=full","pubTime":"2025-06-26 10:15","pubTimestamp":1750904159,"startTime":"0","endTime":"0","summary":"华润三九为医药行业头部企业，以CHC为核心，通过并购 昆药集团 与 天士力 完善银发健康与创新中药布局。我们认为CHC业务凭借品牌优势与渠道优势展现出较强的经营韧性，处方药业务消化集采影响后有望企稳回升，对昆药集团与天士力的收购有望推动公司的跨越式发展，维持“增持”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626102819a4be5099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626102819a4be5099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000999","BK0012","BK0175","BK0196","BK0060","BK0239","BK0010","BK0185","600535","BK0188","BK0183","BK0028"],"gpt_icon":0},{"id":"2546254132","title":"华润三九控股子公司昆药集团为两孙公司提供1250万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2546254132","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546254132?lang=zh_cn&edition=full","pubTime":"2025-06-25 08:08","pubTimestamp":1750810137,"startTime":"0","endTime":"0","summary":"中访网数据 华润三九医药股份有限公司公告披露，其控股子公司昆药集团股份有限公司近日为旗下两家孙公司提供总额1250万元的融资担保。本次担保后，昆药集团对两家公司的实际担保余额增至3370万元，占其最近一期经审计净资产的1.56%。目前，昆药集团及其子公司对外担保余额1.1385亿元，无逾期记录。此外，华润三九另一控股子公司天士力对外担保余额4.3458亿元，均未涉及关联方或表外担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625081217952a4338&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625081217952a4338&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","BK0012","BK0188","BK0185","BK0196","BK0028","BK0239","000999","600422","BK0183","BK0010","BK0060"],"gpt_icon":0},{"id":"2545498407","title":"研报掘金丨东吴证券：首予天士力“买入”评级，华润入主强强联合","url":"https://stock-news.laohu8.com/highlight/detail?id=2545498407","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545498407?lang=zh_cn&edition=full","pubTime":"2025-06-23 15:47","pubTimestamp":1750664851,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0175","601555","BK0188","BK0012","BK0185","BK0009","BK0060","BK0183","BK0276","BK0010","BK0196","BK0239","000999","BK0028","600535"],"gpt_icon":0},{"id":"2545468792","title":"华润三九：6月11日投资者关系活动记录，国联民生、中信建投等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2545468792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545468792?lang=zh_cn&edition=full","pubTime":"2025-06-23 10:30","pubTimestamp":1750645855,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年6月20日华润三九发布公告称公司于2025年6月11日投资者关系活动记录，国联民生、中信建投、富国基金、惠理基金、中金公司、兴业证券、东方证券、平安养老参与。昆药和天士力会进一步巩固华润三九的行业地位，加快达成华润三九争做行业头部企业的战略目标。天士力会在多方面为华润三九业务提供新的价值，共同推动天士力业务有更好的发展，争取成为中药创新药的引领者，医疗端的第一品牌。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300005017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01456","BK0028","BK0175","BK0012","BK0185","BK1147","601456","BK0276","601066","BK0239","BK0188","000999","BK0196","BK1564","BK0010","BK0060","BK0183"],"gpt_icon":0},{"id":"2544519164","title":"华润三九：公司高度重视市值管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2544519164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544519164?lang=zh_cn&edition=full","pubTime":"2025-06-19 20:48","pubTimestamp":1750337294,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九06月18日在投资者关系平台上答复投资者关心的问题。公司高度重视市值管理工作，已根据相关政策及法律法规制定《市值管理制度》。公司践行以投资者为本的发展理念，围绕公司发展战略，聚焦主业发展，持续提升公司核心竞争力，重视股东回报，持续现金分红，推动高质量发展，切实履行上市公司责任，为稳市场、稳信心积极贡献力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061900033689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0183","BK0010","000999","BK0188","BK0239","BK0060","BK0012","BK0196","BK0175","BK0028"],"gpt_icon":0},{"id":"2543695888","title":"东方妍美赴港上市 押注童颜针四年估值涨近七倍【IPO观察】","url":"https://stock-news.laohu8.com/highlight/detail?id=2543695888","media":"投资者网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543695888?lang=zh_cn&edition=full","pubTime":"2025-06-15 08:01","pubTimestamp":1749945716,"startTime":"0","endTime":"0","summary":"四年估值上涨近七倍据招股书披露。2023年，东方妍美成立，并全资控股了江苏西宏。若从江苏西宏的天使轮算起，到东方妍美递表前的最后两轮融资，四年时间，东方妍美的估上涨了近七倍。叠加行政开支，导致东方妍美连续亏损。多家公司角逐“童颜针”东方妍美要扭转亏损局势，只有等待核心产品XH301上市。截至2024年末，东方妍美账上的现金及现金等价物只有3319.7万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/15080151078687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688621","00867","IE00BYV24P56.USD","LU0971096721.USD","BK0185","300896","BK0188","BK0183","LU1363072403.SGD","IE00BVYPNP33.GBP","BK1191","LU2328871848.SGD","SG9999004220.SGD","600200","BK0028","BK0201","LU0882574139.USD","BK0251","SG9999015978.USD","BK4006","LU0267386448.USD","IE00BHPRN162.USD","300003","LU0170899867.USD","BK0196","CMC","BK0113","BK1593","IE00BZ1G4Q59.USD","BK0132","BK0216","LU1969619763.USD","BK0042","LU2488822045.USD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","IE00B1BXHZ80.USD","BK0114","SG9999015986.USD","BK0175","BK0239","000963","000999","BK0012","BK0187","603127","BK0209","BK0010","IE00BKVL7J92.USD","LU0149725797.USD"],"gpt_icon":0},{"id":"2543971500","title":"华润三九：截至6月10日公司股东共60483户","url":"https://stock-news.laohu8.com/highlight/detail?id=2543971500","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543971500?lang=zh_cn&edition=full","pubTime":"2025-06-13 17:39","pubTimestamp":1749807547,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九(000999)06月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘：你好！请问截止至2025年6月10日，公司的股东人数是多少？谢谢！华润三九回复：您好，截至6月10日，公司股东共60,483户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061300027045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","BK0028","BK0188","BK0060","BK0183","000999","BK0185","BK0012","BK0175","BK0010"],"gpt_icon":0},{"id":"2541221895","title":"每周股票复盘：华润三九（000999）股东户数减少，预计2025年营收双位数增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2541221895","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541221895?lang=zh_cn&edition=full","pubTime":"2025-06-07 05:30","pubTimestamp":1749245435,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘，华润三九报收于32.69元，较上周的42.95元下跌23.89%。本周关注点股本股东变化：截至2025年5月31日公司股东户数为5.82万户，较5月20日减少2533.0户机构调研要点：公司预计2025年营业收入将实现双位数的增长股本股东变化近日华润三九披露，截至2025年5月31日公司股东户数为5.82万户，较5月20日减少2533.0户，减幅为4.17%。整体来看,公司预计2025年公司营业收入将实现双位数的增长,净利润将匹配营收增长水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700007417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000999"],"gpt_icon":0},{"id":"2541885081","title":"华润三九Q1营利双降，甩卖亏损资产难掩并购扩张隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2541885081","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541885081?lang=zh_cn&edition=full","pubTime":"2025-06-06 10:34","pubTimestamp":1749177280,"startTime":"0","endTime":"0","summary":"证券之星注意到，于甩包袱的华润三九而言，支撑其规模扩张的并购策略正面临严峻考验：收入囊中的昆药集团营收增长停滞且业绩骤降，新控股的天士力业绩下滑，叠加一季度公司自身营收净利双降，以及因频繁并购累积的逾77亿元巨额商誉减值风险，扩张之路隐忧重重。基于上述战略目标，华润三九近期频繁“甩不良资产”。尽管去年华润三九营利保持双位数增长，但也暗藏隐忧。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025060600009633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0239","BK0188","BK0012","BK0060","BK0185","BK0183","BK0010","000999","BK0175"],"gpt_icon":0},{"id":"2541604902","title":"华润三九：截至5月31日公司股东共58187户","url":"https://stock-news.laohu8.com/highlight/detail?id=2541604902","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541604902?lang=zh_cn&edition=full","pubTime":"2025-06-05 15:30","pubTimestamp":1749108628,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九(000999)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到5月31日公司股东人数是多少？华润三九回复：您好，截至5月31日，公司股东共58,187户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060500016443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","BK0196","BK0012","BK0183","000999","BK0175","BK0010","BK0185","BK0188","BK0239"],"gpt_icon":0},{"id":"2540089255","title":"华润三九：5月27日投资者关系活动记录，中信证券、太平资产等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2540089255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540089255?lang=zh_cn&edition=full","pubTime":"2025-06-04 09:32","pubTimestamp":1749000724,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年6月3日华润三九发布公告称公司于2025年5月27日投资者关系活动记录，中信证券、太平资产、中欧基金、国投瑞银、普徕仕、国投证券参与。全年来看,CHC感冒、皮肤、胃肠、骨科等均有相应的市场机会。天士力会在多方面为华润三九业务提供新的价值,共同推动天士力业务有更好的发展,争取成为中药创新药的引领者,医疗端的第一品牌。华润三九主营业务：药品的开发、生产、销售和医疗保健服务等业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400005980.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0010","LU2495084118.USD","BK0028","BK1521","BK0060","LU1997245177.USD","06030","BK0276","600030","000999","BK0183","LU1997245094.SGD","LU0405327148.USD","LU0405327494.USD","LU2148510915.USD","LU1064130708.USD","BK0185","BK0239","LU2289578879.USD","BK0196","LU1328615791.USD","LU1997244956.HKD","BK0188","BK1564","BK1516","LU1064131003.USD","BK1147","LU1720050803.USD","BK0175","LU1655091616.SGD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2540770464","title":"华润三九：会加快与天士力在产品、渠道、终端等方面的协同","url":"https://stock-news.laohu8.com/highlight/detail?id=2540770464","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540770464?lang=zh_cn&edition=full","pubTime":"2025-06-03 22:39","pubTimestamp":1748961540,"startTime":"0","endTime":"0","summary":"人民财讯6月3日电，就“公司对于天士力后续整合规划”的问题，华润三九近日表示，未来公司会继续鼓励天士力以创新驱动业务发展，强化研发投入，推动研发效率提升，方向上聚焦心血管及代谢、中枢神经、消化等重要领域，丰富研发管线，提升研发能力。同时会注重天士力和华润三九业务上的协同赋能，后续会加快双方在产品、渠道、终端等方面的协同。（文章来源：人民财讯）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603224040950d1262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603224040950d1262&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600535","BK0196","BK0188","BK0012","BK0239","BK0060","BK0185","BK0183","BK0010","000999","BK0175"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752470612625,"stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.045},{"period":"3month","weight":-0.0735},{"period":"6month","weight":-0.0406},{"period":"1year","weight":0.0064},{"period":"ytd","weight":-0.0778}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.084},{"period":"6month","weight":0.1078},{"period":"1year","weight":0.1817},{"period":"ytd","weight":0.0473}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华润三九医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"65625人(较上一季度增加8.50%)","perCapita":"25326股","listingDate":"2000-03-09","address":"广东省深圳市龙华区观湖街道观澜高新园区观清路1号","registeredCapital":"166958万元","survey":" 华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是CHC健康消费品、处方药。报告期内，公司获得中国质量协会QC成果发表赛一等奖。","listedPrice":8.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润三九(000999)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润三九(000999)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润三九,000999,华润三九股票,华润三九股票老虎,华润三九股票老虎国际,华润三九行情,华润三九股票行情,华润三九股价,华润三九股市,华润三九股票价格,华润三九股票交易,华润三九股票购买,华润三九股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润三九(000999)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润三九(000999)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}